Suppr超能文献

采用电喷雾电离质谱研究 N 配位配体的钌(II)茂基衍生配合物的气相行为:碎裂途径和能量学。

Gas-phase behaviour of Ru(II) cyclopentadienyl-derived complexes with N-coordinated ligands by electrospray ionization mass spectrometry: fragmentation pathways and energetics.

机构信息

Centro de Química e Bioquímica, Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.

出版信息

Rapid Commun Mass Spectrom. 2012 Aug 15;26(15):1675-86. doi: 10.1002/rcm.6276.

Abstract

RATIONALE

The gas-phase behaviour of six Ru(II) cyclopentadienyl-derived complexes with N-coordinated ligands, compounds with antitumor activities against several cancer lines, was studied. This was performed with the intent of establishing fragmentation pathways and to determine the Ru-L(N) and Ru-L(P) ligand bond dissociation energies. Such knowledge can be an important tool for the postulation of the mechanisms of action of these anticancer drugs.

METHODS

Two types of instruments equipped with electrospray ionisation were used (ion trap and a Fourier transform ion cyclotron resonance (FTICR) mass spectrometer). The dissociation energies were determined using energy-variable collision-induced dissociation measurements in the ion trap. The FTICR instrument was used to perform MS(n) experiments on one of the compounds and to obtain accurate mass measurements. Theoretical calculations were performed at the density functional theory (DFT) level using two different functionals (B3LYP and M06L) to estimate the dissociation energies of the complexes under study.

RESULTS

The influence of the L(N) on the bond dissociation energy (D) of RuCp compounds with different nitrogen ligands was studied. The lability order of L(N) was: imidazole<1-butylimidazole<5-phenyl-1H-tetrazole<1-benzylimidazole. Both the functionals used gave the following ligand lability order: imidazole<1-benzylimidazole<5-phenyl-1H-tetrazole<1-butylimidazole. It is clear that there is an inversion between 1-benzylimidazole and 1-butylimidazole for the experimental and theoretical lability orders. The M06L functional afforded values of D closer to the experimental values. The type of phosphane (L(P) ) influenced the dissociation energies, with values of D being higher for Ru-L(N) with 1-butylimidazole when the phosphane was 1,2-bis(diphenylphosphino)ethane. The Ru-L(P) bond dissociation energy for triphenylphosphane was independent of the type of complex.

CONCLUSIONS

The D values of Ru-L(N) and Ru-L(P) were determined for all six compounds and compared with the values calculated by the DFT method. For the imidazole-derived ligands the energy trend was rationalized in terms of the increasing extension of the σ-donation/π-backdonation effect. The bond dissociation energy of Ru-PPh(3) was independent of the fragmentations.

摘要

背景

研究了六种具有抗肿瘤活性的 Ru(II) 茂基衍生配合物的气相行为,这些配合物的 N 配位配体。这是为了建立断裂途径,并确定 Ru-L(N)和 Ru-L(P)配体键离解能。这种知识可以成为推测这些抗癌药物作用机制的重要工具。

方法

使用两种配备电喷雾电离的仪器(离子阱和傅立叶变换离子回旋共振(FTICR)质谱仪)进行研究。使用离子阱中的能量可变碰撞诱导解离测量来确定离解能。FTICR 仪器用于对其中一种化合物进行 MS(n) 实验,并获得精确的质量测量。使用两种不同的函数(B3LYP 和 M06L)在密度泛函理论(DFT)水平上进行理论计算,以估计所研究配合物的离解能。

结果

研究了不同氮配体的 RuCp 化合物中 L(N)对键离解能(D)的影响。L(N)的不稳定性顺序为:咪唑<1-丁基咪唑<5-苯基-1H-四唑<1-苄基咪唑。两种函数都给出了以下配体不稳定性顺序:咪唑<1-苄基咪唑<5-苯基-1H-四唑<1-丁基咪唑。显然,实验和理论不稳定性顺序之间存在 1-苄基咪唑和 1-丁基咪唑的反转。M06L 函数提供了更接近实验值的 D 值。膦配体(L(P))的类型也影响了离解能,当膦为 1,2-双(二苯基膦)乙烷时,Ru-L(N)与 1-丁基咪唑的 D 值较高。三苯基膦的 Ru-L(P)键离解能与配合物的类型无关。

结论

确定了所有六种化合物的 Ru-L(N)和 Ru-L(P)的 D 值,并与 DFT 方法计算的值进行了比较。对于咪唑衍生的配体,能量趋势可以根据σ-给予/π-回授效应的增加来合理化。Ru-PPh(3)的键离解能与片段化无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验